This workshop brings together stakeholders in the care of patients with muscle-invasive bladder cancer including clinicians, regulatory scientists, biostatisticians, patients, advocates, and industry representatives. Its goals are to define the current state of knowledge regarding endpoints to accelerate the development of systemic therapy regimens in the neoadjuvant setting, identify knowledge gaps, plan strategies for evidence development and generate regulatory guidance to inform ongoing/future clinical trials.

Location: Capital Hilton, Washington, DC, United States

2019 Program